Season 1 Episode 188
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews neurologist Michio Hirano, MD, of Columbia University in New York about an investigative therapy that shows promise in treating thymidine kinase 2 deficiency (TK2d), an ultrarare disease.
Published on 3 months, 3 weeks ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate